Atlas Trials

Multicenter Randomized Double Blind Controlled-study to Assess the Potential of Methotrexate Versus Placebo to Improve and Maintain Response to Anti TNF- Alpha Agents in Adult Patients With Moderate to Severe Psoriasis

Clinical trial NCT02829424 · TERMINATED

Trial details

NCT number
NCT02829424
Sponsor
Assistance Publique Hopitaux De Marseille
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Psoriasis
Start date
2017-01-23
Primary completion
2023-01-10
Enrollment
78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.